The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117)
Open accessAbstract
A hierarchy of progenitor cells is thought to exist in human acute myeloid leukemia (AML), with only the most primitive cells capable of proliferating to maintain the malignant clone. To further characterize this AML cell hierarchy, we evaluated the coexpression of CD34 and c-kit (CD117) on cells that are capable of long-term proliferation in vitro and in vivo.AML cells were sorted for coexpression of CD34 and c-kit (CD117) using two c-kit monoclonal antibodies (mAbs), clones 95C3 and 104D2. Sorted subfractions were evaluated for the ability to produce colony-forming units (CFU) for up to 8 weeks in suspension culture (SC) and for the capacity to repopulate NOD/SCID mice. When expression of c-kit on blood cells from 19 AML patients at diagnosis was compared using both mAbs, expression defined by 104D2 (34% +/- 6% c-kit(+)) was somewhat higher than that defined using 95C3 (18% +/- 4%). AML cells were sorted for coexpression of CD34 and c-kit using both c-kit mAbs, and the subfractions were assayed in vitro and in vivo. Whereas the majority of AML blast cells lacked expression of CD34, most AML cells capable of proliferating to produce CFU after 4 to 8 weeks in SC were CD34(+)/c-kit(-). Cultures of sorted CD34(+)/c-kit(-) cells, supplemented with steel factor, were composed of a large proportion (18% to 87%) of CD34(+)/c-kit(+) cells after 1 week, suggesting that either c-kit expression was upregulated or CD34(+)/c-kit(+) cells were produced. Moreover, the CD34(+)/c-kit(-) subfraction was found to be capable of responding to steel factor alone to produce CFU after 4 weeks in SC. In most AML patients tested (11/15), the only sorted subfraction capable of engrafting NOD/SCID mice was CD34(+)/c-kit(-). The CD34(+)/c-kit(+) subfraction from only 2 of the 15 patients and CD34(-) cells from 3 patients also engrafted the NOD/SCIDs. Only the CD34(+)/c-kit(+) subfraction of normal bone marrow engrafted. These studies suggest that primitive AML cells capable of long-term proliferation in vitro and NOD/SCID repopulation differ from primitive normal progenitor cells in their lack of surface expression of c-kit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AML leukemia initiating cells frequently have surface-phenotype features of lineage-commitment (CD34+38+, CLL-1+, CD71+, CD90−, c-Kit-)(42–52).”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [48]
Citations
Cites
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864 · cited 3×
“Discussion Previous studies by ourselves [2,4,5] and others [1,3] demonstrated that the ability to reproduce AML in vivo is confined to a small subset of all AML blast cells that is phenotypically similar to normal primitive progenitors.”
BackgroundA cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783 · cited 2×
“Discussion Previous studies by ourselves [2,4,5] and others [1,3] demonstrated that the ability to reproduce AML in vivo is confined to a small subset of all AML blast cells that is phenotypically similar to normal primitive progenitors.”
BackgroundLong-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140 · cited 1×
“Reports over the last 3 years have suggested that the most primitive normal hematopoietic progenitor cells lack expression of CD34 [42–45].”
BackgroundHuman proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.
Yarden, Y., Kuang, W. J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T. J., Chen, E., Schlessinger, J., Francke, U., & Ullrich, A. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02655.x · Cited by 1,574 · cited 1×
“The proto-oncogene c-kit encodes a transmembrane receptor tyrosine kinase (p145 c-kit ) [6].”
BackgroundZsebo, K. M., Williams, D. A., Geissler, E. N., Broudy, V. C., Martin, F. H., Atkins, H. L., Hsu, R.-Y., Birkett, N. C., Okino, K. H., Murdock, D. C., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90302-u · Cited by 1,388 · cited 2×
“C-kit and its ligand have been shown to be important for normal hematopoietic development as demonstrated by mapping of c-kit to the W locus in the mouse [10,11] and steel factor to the Steel locus [7,9,12].”
BackgroundThe dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene
Geissler, E. N., Ryan, M. A., & Housman, D. E. (1988) · Cell · doi:10.1016/0092-8674(88)90020-7 · Cited by 1,287 · cited 1×
“C-kit and its ligand have been shown to be important for normal hematopoietic development as demonstrated by mapping of c-kit to the W locus in the mouse [10,11] and steel factor to the Steel locus [7,9,12].”
BackgroundHuang, E., Nocka, K., Beier, D. R., Chu, T.-Y., Buck, J., Lahm, H.-W., Wellner, D., Leder, P., & Besmer, P. (1990) · Cell · doi:10.1016/0092-8674(90)90303-v · Cited by 1,155 · cited 2×
“C-kit and its ligand have been shown to be important for normal hematopoietic development as demonstrated by mapping of c-kit to the W locus in the mouse [10,11] and steel factor to the Steel locus [7,9,12].”
BackgroundThe proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus
Chabot, B., Stephenson, D. A., Chapman, V. M., Besmer, P., & Bernstein, A. (1988) · Nature · doi:10.1038/335088a0 · Cited by 994 · cited 1×
“C-kit and its ligand have been shown to be important for normal hematopoietic development as demonstrated by mapping of c-kit to the W locus in the mouse [10,11] and steel factor to the Steel locus [7,9,12].”
BackgroundExpression and function of c-kit in hemopoietic progenitor cells.
Ogawa, M., Matsuzaki, Y., Nishikawa, S., Hayashi, S., Kunisada, T., Sudo, T., Kina, T., Nakauchi, H., & Nishikawa, S. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.1.63 · Cited by 743 · cited 1×
“c-kit expression has been found to be restricted to stem and myeloid progenitor cells in both human [13–16] and murine bone marrow (BM) [17–20].”
BackgroundIkuta, K., & Weissman, I. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1502 · Cited by 636 · cited 1×
“c-kit expression has been found to be restricted to stem and myeloid progenitor cells in both human [13–16] and murine bone marrow (BM) [17–20].”
Background
Research works printed but not linked: 2
- Reuss-Borst, 1994, Aml, Leukemia, 8, 258
- Ashman, 1997, CD117 workshop panel report
Cited by
The Biology of Cancer Stem Cells
Lobo, N. A., Shimono, Y., Qian, D., & Clarke, M. F. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104154 · Cited by 1,043
“More recent studies have expanded the definition of the LSC in AML to the phenotypic CD34 + CD38 − CD90 − IL − 3R + CD71 − HLA − DR − CD117 − population (Blair & Sutherland 2000; Blair et al. 1997, 1998; Jordan et al. 2000).”
MethodTumour-initiating cells: challenges and opportunities for anticancer drug discovery
Zhou, B.-B. S., Zhang, H., Damelin, M., Geles, K. G., Grindley, J. C., & Dirks, P. B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2137 · Cited by 841
“However, there seem to be some phenotypic differences between leukaemia-initiating cells and HSCs, including differences in the expression of THY1 membrane glycoprotein, KIT and IL-3 receptor-α ( IL3RA”
BackgroundNuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
Guzman, M. L., Neering, S. J., Upchurch, D., Grimes, B., Howard, D. S., Rizzieri, D. A., Luger, S. M., & Jordan, C. T. (2001) · Blood · doi:10.1182/blood.v98.8.2301 · Cited by 758
Guzman, M. L., Rossi, R. M., Karnischky, L., Li, X., Peterson, D. R., Howard, D. S., & Jordan, C. T. (2005) · Blood · doi:10.1182/blood-2004-10-4135 · Cited by 678
Cancer stem cells: lessons from leukemia
Wang, J. C. Y., & Dick, J. E. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.07.004 · Cited by 615
“In particular, Thy-1 (CD90) and c-kit (CD117) are expressed on normal HSCs but are lacking on LSCs [19, 20 ], whereas the IL-3 receptor a chain (CD123) is a unique marker for LSCs [21].”
Background
Metadata
- Authors
- Blair, A., & Sutherland, H. J.
- Affiliations
- BC Cancer Agency (CA)
- Corresponding author
- Sutherland, Heather J
- Venue
- Experimental Hematology
- Publisher
- Elsevier BV
- Published
- 2000-06
- Volume
- 28
- Issue
- 6
- Pages
- 660-671
- ISSN
- 0301-472X (ISSN-L)
- OpenAlex
- W2008960258
- Cited by
- 165
- References
- 46
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 1 · 2021: 2 · 2020: 4 · 2019: 7 · 2018: 6 · 2017: 9 · 2016: 2 · 2015: 3 · 2014: 5 · 2013: 13 · 2012: 8
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 8042 d)
- Locations
- Experimental Hematology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Terry Fox Foundation
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- acute myeloid leukemia, CD117, CD34, stem cell factor, colony-forming units, hematopoietic progenitor cells, leukemia stem cells, cell surface markers
- MeSH terms
- Acute Disease, Animals, Chromosome Aberrations, Hematopoietic Stem Cells, Humans, Karyotyping, Leukemia, Myeloid, Neoplasm Proteins, Neoplasm Transplantation, Phenotype, Tumor Cells, Cultured, Neoplastic Stem Cells, Gene Expression Regulation, Leukemic, Mice, SCID, Mice, Inbred NOD, Culture Media, Serum-Free, Antigens, CD34, Proto-Oncogene Proteins c-kit, Stem Cell Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). https://app.cochat.ai/papers/10.1016/s0301-472x(00)00155-7
- The paper
- Blair, A., & Sutherland, H. J. (2000). Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Experimental Hematology. https://doi.org/10.1016/s0301-472x(00)00155-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.